Tilray is exiting New Zealand’s medical cannabis market to focus on Australia
Tilray Medical is leaving New Zealand’s medical cannabis market to focus on its MMJ operations in Australia.
Tilray Medical is leaving New Zealand’s medical cannabis market to focus on its MMJ operations in Australia.
New Zealand’s body of senior ministers has approved rule changes that will make it easier for the nation’s medical marijuana operators to export their products.
New Zealand medical cannabis company Cannasouth Limited has entered voluntary administration, a process that allows for an administrator to review and rearrange the financial affairs of insolvent or near-insolvent companies.
Low-dose CBD products will be legal to buy without a prescription in New Zealand, but it might be a while before they’re available.
Preliminary results show a slim majority of voters in New Zealand rejected the country’s referendum on a proposed bill to legalize and regulate sales of adult-use cannabis, the country’s Electoral Commission announced Friday.
The New Zealand government has issued a request for proposals to provide the nation’s physicians with a primer on medical marijuana and its use as a medicine.